Cision PR Newswire

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...

Kavalan Completes Its ‘Sherry Family’ With Rare Palo Cortado Cask

Exceptional whisky delivers hints of vanilla fruitcake, fragrant cardamom, and orange pound cake TAIPEI, Feb. 18, 2025 /PRNewswire/ -- Kavalan Distillery's latest expression...

Razor Labs Enters Subscription Agreement with SIMEC Mining Following Initial Pilot Phase

SYDNEY, Feb. 18, 2025 /PRNewswire/ -- Razor Labs (TASE: RZR), a leader in AI-driven predictive maintenance solutions, announced today its new subscription agreement with SIMEC Mining,...

CGTN: Initiative bridging film and travel launches in Beijing

BEIJING, Feb. 18, 2025 /PRNewswire/ -- The latest Chinese animated blockbuster, Ne Zha II, has taken the global box office by storm, surpassing 12...

MANHATTAN ASSOCIATES AUSTRALIA CERTIFIED AS A GREAT PLACE TO WORK FOR 2025

SYDNEY, Feb. 18, 2025 /PRNewswire/ -- Manhattan Associates Inc. (NASDAQ: MANH) is proud to announce that its Australian office has once again been recognised...

ClassDojo CTO backs kid-tech gaming app, Polymath in $1M raise

AUCKLAND, New Zealand, Feb. 18, 2025 /PRNewswire/ -- Kid-tech startup Polymath has secured $1M USD in funding with notable investment from ClassDojo CTO Liam Don...